文献速递乳腺癌放疗放疗物理与技术

乳腺癌放射治疗中使用的器官保护技术与剂量体积限值——欧洲与拉丁美洲调查结果

Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy - Results from European and Latin American surveys.
PubMed 文献 · Clin Transl Radiat Oncol · 2024-02-19

该在线调查收集了来自57个国家585名放射肿瘤学医生的回复,评估乳腺癌放疗中危及器官勾画与保护技术的实践差异。欧洲与拉丁美洲和加勒比地区参与者最常勾画的危及器官为全心脏、同侧肺及对侧肺等,IMRT与VMAT为心脏保护首选技术。仅少数医生报告常规临床实践中使用的危及器官剂量体积限值,平均心脏剂量4至5 Gy为最常报告参数。

要点

  • 欧洲与拉丁美洲参与者最常勾画的危及器官为全心脏(96.6%与97.7%)、同侧肺(84.3%与90.8%)。
  • 心脏保护策略首选IMRT(68.6%与59.1%)与VMAT(65.6%与60.2%),其次为DIBH(54.8%与37.4%)。
  • 仅少数放射肿瘤学医生报告常规临床实践中危及器官的剂量体积限值,平均心脏剂量4至5 Gy最常被报告(17.2%与39.3%)。

核心结论

  • 全球放射肿瘤学医生在乳腺癌放疗中危及器官的勾画方法与保护技术存在差异。
  • 剂量限值相关问题的低回复率反映该领域存在不确定性,支持临床实践中需要详细的共识推荐。

研究设计与样本

  • 通过个人联系、放射肿瘤学与乳腺癌专业组网络向欧洲及拉丁美洲和加勒比地区执业的放射肿瘤学医生发放在线调查。
  • 研究纳入来自57个不同国家的585份回复,收集人口学数据与临床实践信息。

主要发现

  • 欧洲与拉丁美洲参与者最常勾画的危及器官为全心脏(96.6%与97.7%)、同侧肺(84.3%与90.8%)、对侧肺(71.3%与77.4%)、全肺(69.8%与72.9%)及对侧乳腺(66.4%与83.2%)。
  • 欧洲参与者偏好ESTRO指南(33.3%),拉丁美洲和加勒比地区最常用RTOG勾画指南(62.2%),部分参与者同时使用两种推荐(13.2%与19.2%)。
  • 心脏保护策略首选IMRT(68.6%与59.1%)与VMAT(65.6%与60.2%),其次为深吸气屏气(DIBH)(54.8%与37.4%)与部分乳腺照射(PBI)(41.6%与24.6%)。
  • 仅小部分放射肿瘤学医生报告常规临床实践中使用的危及器官剂量体积限值,平均心脏剂量(Heart-Dmean)4至5 Gy为最常报告参数(17.2%与39.3%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advances in local and systemic therapies have improved the outcomes of patients with breast cancer (BC), leading to a possible increased risk for postoperative radiation therapy (RT) late adverse events. The most adequate technologies and dose constraints for organs at risk (OAR) in BC RT have yet to be defined. METHODS: An online survey was distributed to radiation oncologists (ROs) practicing in Europe and Latin America including the Caribbean (LAC) through personal contacts, RO and BC professional groups' networks. Demographic data and clinical practice information were collected. RESULTS: The study included 585 responses from ROs practicing in 57 different countries. The most frequently contoured OAR by European and LAC participants were the whole heart (96.6 % and 97.7 %), the ipsilateral (84.3 % and 90.8 %), and contralateral lung (71.3 % and 77.4 %), whole lung (69.8 % and 72.9 %), and the contralateral breast (66.4 % and. 83.2 %). ESTRO guidelines were preferred in Europe (33.3 %) and the RTOG contouring guideline was the most popular in LAC (62.2 %), while some participants used both recommendations (13.2 % and 19.2 %). IMRT (68.6 % and 59.1 %) and VMAT (65.6 % and 60.2 %) were the preferred modalities used in heart sparing strategies, followed by deep inspiration breath-hold (DIBH) (54.8 % and 37.4 %) and partial breast irradiation (PBI) (41.6 % and 24.6 %). Only a small percentage of all ROs reported the dose-volume constraints for OAR used in routine clinical practice. A mean heart dose (Heart-Dmean) between 4 and 5 Gy was the most frequently reported parameter (17.2 % and 39.3 %). CONCLUSION: The delineation approaches and sparing techniques for OAR in BC RT vary between ROs worldwide. The low response rate to the dose constraints subset of queries reflects the uncertainty surrounding this topic and supports the need for detailed consensus recommendations in the clinical practice.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Chirilă ME, Kraja F, Marta GN, et al. Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy - Results from European and Latin American surveys. Clin Transl Radiat Oncol. 2024. PMID: 38425691. doi:10.1016/j.ctro.2024.100752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。